ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models-Reference-Cited by-同舟云学术

ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models

Published:2016-05 Issue: Volume:95 Page:57-64
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kang Han Na,Kim Se-Ho,Yun Mi Ran,Kim Hye Ryun,Lim Sun Min,Kim Min-Soo,Hong Kwang-Won,Kim Sung-Moo,Kim Hwan,Pyo Kyoung-Ho,Park Hye Ji,Han Joo Yeun,Youn Hyun A,Chang Ki-Hwan,Cho Byoung Chul

Funder

Ministry of Education, Science and Technology, Republic of Korea

Ministry of Health & Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors;Burgess;Mol. Cell,2003

2. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc. Natl. Acad. Sci. U.S.A.,2004

5. Targeting the epidermal growth factor receptor for cancer therapy;Mendelsohn;J. Clin. Oncol.,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab;Journal of Radioanalytical and Nuclear Chemistry;2023-04-26

2. Discovery of Potent Dual EGFR/HER2 Inhibitors Based on Thiophene Scaffold Targeting H1299 Lung Cancer Cell Line;Pharmaceuticals;2020-12-24

3. Pharmacophore modeling, 3D‐QSAR, synthesis, and anti‐lung cancer evaluation of novel thieno[2,3‐ d ][1,2,3]triazines targeting EGFR;Archiv der Pharmazie;2020-01-02

4. Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer;Journal of Magnetism and Magnetic Materials;2019-07

5. Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer;Molecules;2019-05-18